Cargando…

Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study

Second primary malignancies (SPM) are described as any primary, not synchronous, malignancy arising in a different anatomical district, with confirmed histological diagnosis. Age at diagnosis, previous non-thyroidal primary malignancy, and radioactive iodine (RAI) therapy have been proposed as indep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piscopo, Leandra, Volpe, Fabio, Nappi, Carmela, Zampella, Emilia, Manganelli, Mariarosaria, Matrisciano, Francesca, Totaro, Pasquale, Pace, Leonardo, Maurea, Simone, Cuocolo, Alberto, Klain, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857292/ https://www.ncbi.nlm.nih.gov/pubmed/36661652 http://dx.doi.org/10.3390/curroncol30010003

Ejemplares similares

Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer
por: Zampella, Emilia, et al.
Publicado: (2023)

Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the OpenDose Project
por: Bianco, Davide, et al.
Publicado: (2022)

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge
por: Klain, Michele, et al.
Publicado: (2020)

Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis
por: Klain, Michele, et al.
Publicado: (2021)

Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
por: Piscopo, Leandra, et al.
Publicado: (2023)

Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report
por: Volpe, Fabio, et al.
Publicado: (2022)

Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives
por: Volpe, Fabio, et al.
Publicado: (2023)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer
por: Piscopo, Leandra, et al.
Publicado: (2022)

Hyperfunctioning parathyroid gland and skeletal involvement on [(18)F]fluorocholine PET/CT: one look with two views
por: Nappi, Carmela, et al.
Publicado: (2022)

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
por: Klain, Michele, et al.
Publicado: (2019)

Advances in Functional Imaging of Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
por: Klain, Michele, et al.
Publicado: (2021)

Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging
por: Nappi, Carmela, et al.
Publicado: (2021)

Incremental Value of Sestamibi SPECT/CT Over Dual-Phase Planar Scintigraphy in Patients With Primary Hyperparathyroidism and Inconclusive Ultrasound
por: Assante, Roberta, et al.
Publicado: (2019)

Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium
por: Nappi, Carmela, et al.
Publicado: (2023)

MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results
por: Maurea, Simone, et al.
Publicado: (2013)

Cardiac hybrid imaging: novel tracers for novel targets
por: Ponsiglione, Andrea, et al.
Publicado: (2021)

Prognostic value of myocardial perfusion imaging by cadmium zinc telluride single-photon emission computed tomography in patients with suspected or known coronary artery disease: a systematic review and meta-analysis
por: Assante, Roberta, et al.
Publicado: (2023)

Age-Specific Cardiovascular Risk Factors for Major Adverse Cardiac Events in Patients Undergoing Myocardial Perfusion Imaging
por: Megna, Rosario, et al.
Publicado: (2023)

External validation and update of the J-ACCESS model in an Italian cohort of patients undergoing stress myocardial perfusion imaging
por: Petretta, Mario, et al.
Publicado: (2023)

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
por: Salvatore, Barbara, et al.
Publicado: (2017)

Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease
por: Nappi, Carmela, et al.
Publicado: (2020)

Radionuclides in the management of thyroid cancer
por: Buscombe, J.R.
Publicado: (2007)

Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging
por: Assante, Roberta, et al.
Publicado: (2021)

Prediction of 2-[(18)F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study
por: Stanzione, Arnaldo, et al.
Publicado: (2023)

Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease
por: Gaudieri, Valeria, et al.
Publicado: (2021)

Prevalence and Severity of Myocardial Perfusion Imaging Abnormalities in Inmate Subjects
por: Assante, Roberta, et al.
Publicado: (2015)

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
por: Riccio, Gennaro, et al.
Publicado: (2016)

Behind Traditional Semi-quantitative Scores of Myocardial Perfusion Imaging: An Eye on Niche Parameters
por: Nappi, Carmela, et al.
Publicado: (2019)

Pitfalls in Risk Stratification: The Case of Acute Pulmonary Embolism
por: Petretta, Mario, et al.
Publicado: (2023)

A Comparison among Different Machine Learning Pretest Approaches to Predict Stress-Induced Ischemia at PET/CT Myocardial Perfusion Imaging
por: Megna, Rosario, et al.
Publicado: (2021)

Revascularization of non-culprit lesions: A common dilemma
por: Cantoni, Valeria, et al.
Publicado: (2022)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

Simultaneous assessment of myocardial perfusion and adrenergic innervation in patients with heart failure by low-dose dual-isotope CZT SPECT imaging
por: Assante, Roberta, et al.
Publicado: (2022)

Nuclear cardiac imaging between implementation and globalization: The key role of integration
por: Cuocolo, Alberto, et al.
Publicado: (2021)

Current role of radionuclide imaging in differentiated thyroid cancer
por: Wong, K.T., et al.
Publicado: (2008)

Regional myocardial perfusion imaging in predicting vessel-related outcome: interplay between the perfusion results and angiographic findings
por: Mannarino, Teresa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8512qt95eds5g491egqdc3gsg7